Document Type : Original Article


1 Department of surgery, SKIMS Medical College, Srinagar, Jammu and Kashmir, India

2 Department of Psychiatry, Government Medical College, Srinagar, Jammu and Kashmir, India

3 Department of mental health services, Hamad Medical Corporation, Doha, Qatar

4 Department of Social and Preventive Medicine, Government Medical College, Srinagar, Jammu and Kashmir, India

5 Department of Psychiatry, Government Medical College, Srinagar, Jammu and Kashmir, India,


BACKGROUND: Vaccine hesitancy is seen, globally, as a major factor that will determine future 
coronavirus disease‑19 (COVID‑19) spread and its effective management. This study aimed to 
identify COVID‑19 vaccine perception, acceptance, confidence, hesitancy, and barriers among the 
general population.
MATERIALS AND METHODS: This was an online survey which was developed and shared through 
social media platforms among the general population of Kashmir. The survey captured demographic 
data and used a validated hesitancy measurement tool. We analyzed the data using descriptive 
statistics and multivariable logistic regression using Stata 15 (Stata Corp. 2017. Stata Statistical 
Software: Release 15. College Station, TX, USA: Stata Corp LLC).
RESULTS: A total of 835 responses were received. Most participants were males, with females 
compromising of 19.5% participants. 65.1% of participants were in the age group of 30–50, whereas 
19.2% were below 30 years of age. 52.70% of respondents were willing to take the vaccine when 
available, while 32.5% of respondents were unsure about their decision of inoculation. The most 
cited reason for willingness to get vaccinated was an understanding of the disease and vaccination. 
41.70% felt that the vaccines developed against COVID‑19 have not been fully tested; therefore, 
concerns around the safety and its longer‑term side effects were the reasons cited. Public health 
messaging should be tailored to address these concerns.
CONCLUSIONS: Vaccine hesitancy is a global threat undermining the control of preventable 
infections. The government should take proactive steps to address the factors that may potentially 
impact the benefits expected from the introduction of a COVID‑19 vaccine in the union territory.


1. Dar SA, Dar MM, Sheikh S, Haq I, Azad AM, Mushtaq M, et al. 
Psychiatric comorbidities among COVID-19 survivors in North 
India: A cross-sectional study. Journal of Education and Health 
Promotion. 2021;10.
2. Mahase E. China coronavirus: WHO declares international 
emergency as death toll exceeds 200. BMJ 2020;368:m408.
3. Available from:‑release/
tion‑world. [Last accessed on 2021 Mar 08].
4. Vaccine Hesitancy: What It Means and What we Need to 
Know in Order to Tackle It. Vaccine‑Preventable Diseases and 
Immunization (VPI/DCE). Available from: https://www.who.
VH_Threat_Child_Health_gvirf16.pdf?ua=1. [last accessed on 
2021 Apr 05].
5. Reluctance to Vaccinate Named a Top Global Health Threat – By 
MJ Altman on January 22, 2019. Available from: https://‑named‑top‑global‑h
ealth‑threat‑in‑2019/. [last accessed on 2021 Apr 05].
6. An Unwanted Booster Dose for Vaccine Hesitancy ‑R. 
Prasad – Updated: November 07, 2019. Available from: https://‑unwanted-booster‑dose‑
for‑vaccine‑hesitancy/article29902812.ece. [last accessed on 2021 
Apr 05].
7. Rao TS, Andrade C. The MMR vaccine and autism: Sensation, 
refutation, retraction, and fraud. Indian J Psychiatry 2011;53:95‑6.
8. Available from:
pdf. [Last accessed on 2021 Mar 10].
9. Taylor S, Landry CA, Paluszek MM, Groenewoud R, Rachor GS, 
Asmundson GJ. A proactive approach for managing COVID‐19: 
The importance of understanding the motivational roots of 
vaccination hesitancy for SARS-CoV2. Front Psychol 2020;11:2890.
10. AP‑NORC Poll: Half of Americans Would Get a COVID‑19 
Vaccine ‑ By Lauran Neergaard and Hannah Fingerhut; 
May 28, 2020. Available from:
dacdc8bc428dd4df6511bfa259cfec44. [last accessed on 2021 Apr 
11. Alabdulla M, Reagu SM, Al‑Khal A, Elzain M, Jones RM. 
COVID‑19 vaccine hesitancy and attitudes in Qatar: A national cross‑sectional survey of a migrant‑majority population. Influenza 
Other Respir Viruses 2021;15:361‑70.
12. Sherman SM, Smith LE, Sim J, Amlôt R, Cutts M, Dasch H, 
et al. COVID-19 vaccination intention in the UK: results from 
the COVID-19 vaccination acceptability study (CoVAccS), a 
nationally representative cross-sectional survey. Human vaccines 
& immunotherapeutics. 2021 Jun 3;17(6):1612-21.
13. Kabamba Nzaji M, Kabamba Ngombe L, Ngoie Mwamba G, 
Banza Ndala DB, Mbidi Miema J, Luhata Lungoyo C, et al. 
Acceptability of vaccination against COVID‑19 among healthcare 
workers in the democratic republic of the Congo. Pragmat Obs 
Res 2020;11:103‑9.
14. Wellcome Global Monitor. How Does the World Feel about 
Science and Health? Available from:
.pdf. [Last accessed on 2021 Mar 09].
15. Petersen E, Wasserman S, Lee SS, Go U, Holmes AH, Al‑Abri S,
et al. COVID‑19‑We urgently need to start developing an exit 
strategy. Int J Infect Dis 2020;96:233‑9.
16. Wang K, Wong EL, Ho KF, Cheung AW, Chan EY, Yeoh EK, et al.
Intention of nurses to accept coronavirus disease 2019 vaccination 
and change of intention to accept seasonal influenza vaccination 
during the coronavirus disease 2019 pandemic: A cross‑sectional 
survey. Vaccine 2020;38:7049‑56.
17. Wang J, Jing R, Lai X, Zhang H, Lyu Y, Knoll MD, et al. Acceptance 
of COVID‑19 Vaccination during the COVID‑19 Pandemic in 
China. Vaccines 2020;8:482.
18. Wong LP, Alias H, Wong PF, Lee HY, AbuBakar S. The use of 
the health belief model to assess predictors of intent to receive 
the COVID‑19 vaccine and willingness to pay. Hum Vaccin 
Immunother 2020;16:2204‑14.
19. Fisher KA, Bloomstone SJ, Walder J, Crawford S, Fouayzi H, 
Mazor KM. Attitudes toward a potential SARS‑CoV‑2 vaccine: 
A survey of U.S. adults. Ann Intern Med 2020;173:964‑73.
20. Sherman SM, Smith LE, Sim J, Amlôt R, Cutts M, Dasch H,
et al. COVID‑19 vaccination intention in the UK: Results from 
the COVID‑19 vaccination acceptability study (CoVAccS), a 
nationally representative cross‑sectional survey. Hum Vaccin 
Immunother 2021;17:1612‑21.
21. LazarusJV, RatzanS, PalayewA, BillariFC, BinagwahoA, KimballS,
et al. COVID‑SCORE: A global survey to assess public perceptions 
of government responses to COVID‑19 (COVID‑SCORE‑10). PLoS 
One 2020;15:e0240011.
22. Available from:
a%20new%20Ips os%20sur vey, to%20get %20vaccinated%20
whe n%20possible. [Last accessed on 2021 Mar 10].
23. INSPIRATION Investigators; Sadeghipour P, Talasaz AH, 
Rashidi F, Sharif‑Kashani B, Beigmohammadi MT, et al. Effect of 
intermediate‑dose vs standard‑dose prophylactic anticoagulation 
on thrombotic events, extracorporeal membrane oxygenation 
treatment, or mortality among patients with COVID‑19 admitted 
to the intensive care unit: The INSPIRATION randomized clinical 
trial. JAMA 2021;325:1620‑30.
24. Harrison EA, Wu JW. Vaccine confidence in the time of COVID‑19. 
Eur J Epidemiol 2020;35:325‑30.
25. Pogue K, Jensen JL, Stancil CK, Ferguson DG, Hughes SJ, Mello EJ, 
et al. Influences on attitudes regarding potential COVID‑19 
vaccination in the united states. Vaccines 2020;8:582.
26. Sallam M. COVID‑19 vaccine hesitancy worldwide: A concise 
systematic review of vaccine acceptance rates. Vaccines (Basel) 
27. Weintraub RL, Subramanian L, Karlage A, Ahmad I, Rosenberg J. 
COVID‑19 vaccine to vaccination: Why leaders must invest in 
delivery strategies now: Analysis describe lessons learned from 
past pandemics and vaccine campaigns about the path to successful 
vaccine delivery for COVID‑19. Health Aff 2021;40:33‑41.
28. Habersaat KB, Betsch C, Danchin M, Sunstein CR, Böhm R, Falk A, 
et al. Ten considerations for effectively managing the COVID‑19 
transition. Nat Hum Behav 2020;4:677‑87.
29. Lin C, Tu P, Beitsch LM. Confidence and receptivity for COVID‑19 
vaccines: A rapid systematic review. Vaccines 2021;9:16